Candida albicans intralesional injection immunotherapy of warts

Cutis

Volumn 70, Issue 3, 2002, Pages 185-192

  Signore, Robert J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CANDIDA ALBICANS; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INTRALESIONAL DRUG ADMINISTRATION; MALE; METHODOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; SKIN DISEASE; TREATMENT OUTCOME; VERRUCA VULGARIS;

ADOLESCENT; ADULT; ANTIGENS, FUNGAL; CANDIDA ALBICANS; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY; INJECTIONS, INTRALESIONAL; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SKIN DISEASES; TREATMENT OUTCOME; WARTS;

EID: 0036730280     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rogers C, Gibney M, Siegfried E, et al. Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo? J Am Acad Dermatol. 1999;41:123-127.
2. Dover JS, Arndt KA, Geronemus RG, et al, eds. Illustrated Cutaneous Laser Surgery: A Practitioner's Guide. Norwalk, Conn: Appleton & Lange; 1990:36.
3. Hurwitz S. Viral diseases of the skin. In: Hurwitz S. Clinical Pediatric Dermatology. Philadelphia, Pa: WB Saunders; 1981:247-253.
4. Lowy DR, Androphy EJ. Warts. In: Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:2484-2497.
5. Matsumoto Y, Adachi A, Banno S, et al. Prominent hyperkeratotic plantar and palmar warts. Cutis. 1999;63:91-94.
6. Bender ME. Concepts of wart regression. Arch Dermatol. 1986;122:644-647.
7. Arndt KA. Warts. In: Arndt KA, Bernhardt MS. Dermatologic Therapeutics With Essentials of Diagnosis. 4th ed. Boston, Mass: Little Brown & Co Inc; 1989.
8. Lee A, Mallory S. Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts. J Am Acad Dermatol. 1999;41:595-599.
9. Lahti A, Hannuksela M. Topical immunotherapy with tuberculin jelly for common warts. Arch Dermatol Res. 1982:273:153-154.
10. Abcarian H, Sharon N. Long-term effectiveness of the immunotherapy of anal condyloma acuminatum. Dis Colon Rectum. 1982;25:648-651.
11. Yurdakok M, Yurdakok K. Vaccine therapy of warts in children. Turk J Pediatr. 1985;27:87-94.
12. Committee on Cutaneous Health and Cosmetics. Treatment of verrucae with smallpox vaccine. JAMA. 1968;206:117.
13. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep. 1998;47(RR-1):88-91.
14. Alam M, Gross E, Savin R. Severe urticarial reaction to diphenylcyclopropenone therapy for alopecia areata. J Am Acad Dermatol. 1999;40:110-111.
15. Puig L, Alegre M, Cuatrecasas M, et al. Erythema multiforme-like reaction following diphencyprone treatment of plane warts. Int J Dermatol. 1994;33:201-203.
16. van der Steen P, Happle R. 'Dyschromia in confetti' as a side effect of topical immunotherapy with diphenylcyclopropenone. Arch Dermatol. 1992;128:518-520.
17. Bolton RA. Nongenital warts: classification and treatment options. Am Fam Physician. 1991;43:2049-2056.
18. Allyn B. Treatment of verruca with vaccinia [letter]. JAMA. 1968;203:807.
19. Brown TJ, Yen-Moore A, Tyring SK. An overview of sexually transmitted diseases - part II. J Am Acad Dermatol. 1999;41:661-677.
20. Iwatsuki K, Tagami H, Takigawa M, et al. Plane warts under spontaneous regression. Arch Dermatol. 1986;122:655-659.
21. Tagami H, Oku T, Iwatsuki K. Primary tissue culture of spontaneously regressing flat warts. Cancer. 1985; 55:2437-2441.
22. Berman A, Winkelmann RK. Involuting common warts. J Am Acad Dermatol. 1980;3:356-362.
23. Berman A, Winkelmann RK. Flat warts undergoing involution. Arch Dermatol. 1977;113:1219-1221.
24. Dahl MV. Host defense: fungus. In: Dahl MV. Clinical Immunodermatology. Chicago, Ill: Year Book Medical Publishing Inc; 1988:171-184.
25. Candin [package insert]. San Diego, Calif: Allermed Laboratories, Inc; 1998.
26. Sanbar SS, Gibofsky A, Firestone MH, et al, eds. Appendix 50-2 The Declaration of Helsinki. Legal Medicine. 5th ed. St Louis, Mo: Mosby; 2001:608.
27. Harada S. Clinical application of fungus extracts and its culture filtrate in the treatment of skin diseases; (3) Candida vaccine in the treatment of warts. Nippon Hifuka Gakkai Zasshi. 1979;89:397-402.
28. Warts refractory to conventional therapy yield to Candida antigen. Leawood, Kan: Am Acad Fam Phys *90 Clinical Perspectives.
29. Allergenic extracts [package insert]. Lenoir, NC: Greer Laboratories, Inc; 1998.
30. Freed DLJ, Eyres KE. Persistent warts protected from immune attack by a blocking factor. Br J Dermatol. 1979;100:731-733.
31. Baldwin RW, Robins RA. Factors interfering with immunological rejection of tumours. Br Med Bull. 1976;32:118-123.
32. Johnson SM, Roberson PK, Horn TD. Intralesional injection of mumps or Candida skin test antigens - a novel immunotherapy for warts. Arch Dermatol. 2001;137:451-455.
33. Phillips RC, Ruhl TS, Pfenniger JL, et al. Treatment of warts with Candida antigen injection. Arch Dermatol. 2000;136:1274-1275.
34. Haller KH. Candida antigen injection proves effective treatment for warts. Available at: http://www.aafp.org /afp/20000115/conference.html. Accessed April 30, 2000.